One-year evaluation of two hybrid composites placed in a randomized-controlled clinical trial.
The aim of this prospective randomized-controlled clinical trial is to assess the long-term performance of two direct composite resins in posterior teeth. This study provides a survey of the one-year results. A total of 1805 restorations were placed by students in stress-bearing Class I/II cavities (including cuspal-coverage) in molars and premolars in 456 patients. Clinical evaluation was performed at baseline and after one year using modified USPHS criteria. The restorations in each patient were performed either with Ceram X/Prime&Bond NT or Tetric Ceram/Optibond Solo Plus. After one year 528 fillings with Ceram X and 580 with Tetric Ceram were available for evaluation of substance loss, contact point, color match, marginal staining, marginal adaptation, secondary caries and radiographic examination (if necessary). This represents a recall rate of 61.18% (279 patients). The failure rate per material was 5.3% in the Ceram X group and 6.1% in the Tetric Ceram group. Most of the failures were associated with marginal adaptation/integrity of the filling. A significant influence on the occurrence of a failure was observed for the number of treated teeth per patient, the age of the patient, the mesio-distal extension of the restoration and the tooth position. Gender, material, a previous root canal treatment, the bucco-lingual extension of the filling or cuspal-coverage did not significantly influence the failure rate. Patients attending the first recall were significantly older and had more fillings than patients not attending. In a group of Class I/II restorations (including cuspal-coverage), there was no significant difference in failure rates between ormocer-based and bis-GMA-based restorative systems after one year. A previous root canal treatment had no negative influence on the failure rate. A longer observation period is indicated to get clear evidence of the long-term performance of these composite resin systems.